Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new Northwestern Medicine multi-site study.
In the near future, patients won’t have to waste time and be disappointed with months of ineffective therapy, scientists said.
“Now we can start to predict which drugs a patient will respond to,” said co-senior author Harris Perlman, chief of rheumatology at Northwestern University Feinberg School of Medicine. “We can truly do precision medicine for rheumatoid arthritis. I believe this could be game changing. ”
The paper was recently published as an uncorrected proof in Arthritis & Rheumatology and will be officially published in the journal in late May. Richard Pope and Deborah Winter also are lead Northwestern authors.
Treatment for rheumatoid arthritis now is trial and error.
“We have so many different biologic drugs and there’s no rhyme or reason to give one drug versus the other,” Perlman said. “We waste $2.5 billion a year in ineffective therapy. And patients go through 12 weeks of therapy, don’t respond and get upset.”
Scientists in the multi-site study were the first in the U.S. to use ultrasound-guided therapy to take a tissue biopsy in the affected joint. In the past, blood samples were used to try to determine the effectiveness of the therapy and disease progression.
“It’s just like oncology, where you go to the tumor,” Perlman said. “Why go anywhere else? In rheumatoid arthritis, we’ve never gone to the target organ.”
Improved ultrasound guided techniques make the new technique possible, Perlman said, noting joint biopsies began in Europe about six years ago.
Scientists in the six-site study analyzed the tissue in 41 rheumatoid arthritis patients, separating out different immune cell populations. They focused on macrophages, essentially the garbage collectors of the immune system that are overactive in rheumatoid arthritis. These cells produce toxic, inflammatory proteins that destroy the joints. Biologic therapy removes the protein molecules being secreted by the macrophages.
The study included 30 patients from Northwestern and the remaining 11 from the University of Alabama at Birmingham; Washington University, Columbia University, Mayo Clinic and University of Michigan.
In the past, scientists have tried to determine therapeutic effectiveness by separating patients into groups based on their clinical parameters such as what antibodies they are producing against themselves, how swollen their joints are and medications they are taking. Then scientists tried to see if these parameters could predict therapeutic efficacy. But that hasn’t worked, Perlman said.
Instead, Perlman and colleagues segregated patients based on the genes being produced by their macrophages. They identified two patient groups who shared aspects of the genetic profiles.
Next, the scientists identified which of these patient populations had joints that were getting better and what biologic therapies they were taking. They also identified a gene sequence associated in patients with early disease. The earlier the patient is treated, the more effective the therapy.
The next goal is to predict which patients will have the best response — based on their genetic signature — to a specific drug.
In a new study, researchers are taking joint biopsy tissue from patients at the start of a new therapy and then six weeks later to see if they can find a predictor gene sequence that will clearly identify which patients respond to a particular therapy.
“The idea is to develop gene sequences to predict whether a patient will respond or not,” Perlman said. “Our goal is that this procedure will become the standard of care of for all patients with rheumatoid arthritis.”
Learn more: Rheumatoid arthritis meets precision medicine
The Latest on: Rheumatoid arthritis
via Google News
The Latest on: Rheumatoid arthritis
- Phone-based intervention aids rheumatoid arthritis care on December 16, 2018 at 1:54 am
(HealthDay)—A nurse-based phone education intervention can promote shared decision making in patients with newly diagnosed rheumatoid arthritis (RA), according to a study published online Dec. 5 ... […]
- How to Make It Through the Holidays When You Have Rheumatoid Arthritis on December 14, 2018 at 4:34 pm
Here’s some tips on how to deal with shopping, parties, travel, and greeting cards. Share on Pinterest Making things easy on yourself is a good strategy during the holidays for people with rheumatoid ... […]
- How This Biotech Stock Could Rival Pfizer, Lilly, AbbVie In Arthritis on December 13, 2018 at 8:42 am
Researchers are studying filgotinib as a rheumatoid arthritis treatment. They also believe it could treat Crohn's disease and ulcerative colitis. "Data from Phase 2 trials and the initial pivotal Phas... […]
- 5 common myths about arthritis on December 12, 2018 at 2:36 pm
But what you might not know is that it really depends on the specific type of arthritis. Typically, people will experience symptoms of osteoarthritis when they reach 70, but rheumatoid arthritis can o... […]
- Planning Ahead or Being Spontaneous: Which Approach Works Better for People With Rheumatoid Arthritis? on December 12, 2018 at 7:44 am
Life doesn’t stop the day you are diagnosed with rheumatoid arthritis. Quite the opposite. It doesn’t take long to realize that you must figure out how to live optimally with rheumatoid arthritis (RA) ... […]
- Dating with a chronic illness: ‘If they reject me just because I have arthritis, then they’re not worth my time and effort anyway’ on December 10, 2018 at 2:36 pm
Dating is tricky enough without throwing in a diagnosis of a chronic autoimmune disease, such as rheumatoid arthritis or multiple sclerosis. But that hasn’t stopped many people with these conditions f... […]
- Woman's Doctor: Know symptoms of rheumatoid arthritis because it's treatable on December 10, 2018 at 1:32 pm
WEBVTT MEGAN CHERYL THRASHER SAYS IT IS : A RELIEF TO BE WALKING LIKE SHE USED TO. UNTIL RECENTLY SOMETHING THIS SIMPLE WAS PAINFUL. >> IT WAS TO WHERE I COULD BARELY WALK, IT TOOK ME 45 MINUTES TO GE... […]
- Your body on arthritis: Why the condition can be so painful and debilitating on December 7, 2018 at 1:44 pm
But there are several forms of arthritis, and the two most common types — osteoarthritis and rheumatoid arthritis — are actually pretty different. Osteoarthritis is associated with wear and tear that ... […]
- The Global Market for Rheumatoid Arthritis Drugs (2018-2022): Analysis by Type of Molecule, Type of RA, Region and Vendor on December 7, 2018 at 9:54 am
The "Global Rheumatoid Arthritis Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The rheumatoid arthritis drugs market will register a CAGR of close to 8% by 2022. […]
via Bing News